These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10395359)

  • 1. Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor?
    Delgado J; Muñoz de Bustillo E; Ibarrola C; Colina F; Morales JM; Rodriguez E; Aguado JM; Fuertes A; Gomez MA
    J Heart Lung Transplant; 1999 Jun; 18(6):607-10. PubMed ID: 10395359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosing cholestatic hepatitis-like syndrome in hepatitis B virus-negative and hepatitis C virus-negative renal transplant recipients.
    Muñoz de Bustillo E; Benito A; Colina F; Andrés A; Domínguez-Gil B; Muñoz MA; Rodicio JL; Morales JM
    Am J Kidney Dis; 2001 Sep; 38(3):640-5. PubMed ID: 11532698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
    Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K
    Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosing cholestatic hepatitis-like syndrome in a hepatitis B virus and hepatitis C virus-negative renal transplant recipient: a case report with autopsy findings.
    Duseja A; Nada R; Kalra N; Acharya SK; Minz M; Joshi K; Chawla Y
    Trop Gastroenterol; 2003; 24(1):31-4. PubMed ID: 12974214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection.
    Rosenberg PM; Farrell JJ; Abraczinskas DR; Graeme-Cook FM; Dienstag JL; Chung RT
    Am J Gastroenterol; 2002 Feb; 97(2):478-83. PubMed ID: 11866292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients.
    Muñoz De Bustillo E; Ibarrola C; Colina F; Castellano G; Fuertes A; Andrés A; Aguado JM; Rodicio JL; Morales JM
    J Am Soc Nephrol; 1998 Jun; 9(6):1109-13. PubMed ID: 9621297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity.
    Romagnuolo J; Sadowski DC; Lalor E; Jewell L; Thomson AB
    Can J Gastroenterol; 1998 Oct; 12(7):479-83. PubMed ID: 9812167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histologic features of Azathioprine-induced hepatotoxicity.
    Siramolpiwat S; Sakonlaya D
    Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe cholestatic hepatitis caused by azathioprine.
    Eisenbach C; Goeggelmann C; Flechtenmacher C; Stremmel W; Encke J
    Immunopharmacol Immunotoxicol; 2005; 27(1):77-83. PubMed ID: 15803861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection.
    Delladetsima JK; Makris F; Psichogiou M; Kostakis A; Hatzakis A; Boletis JN
    Liver; 2001 Apr; 21(2):81-8. PubMed ID: 11318976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early histologic changes in fibrosing cholestatic hepatitis C.
    Dixon LR; Crawford JM
    Liver Transpl; 2007 Feb; 13(2):219-26. PubMed ID: 17205558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease.
    Błogowski W; Marlicz W; Smereczyński A; Lawniczak M; Lewosiuk A; Starzyńska T
    Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):398-402. PubMed ID: 20726808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute hepatitis C infection with prolonged intrahepatic cholestasis and remarkable progression of fibrosis mimicking fibrosing cholestatic hepatitis].
    Akagi H; Mizuki A; Tominaga T; Seki Y; Nakajima R; Matsumoto Y; Nakashita M; Okazawa A; Sato T; Nagata H
    Nihon Shokakibyo Gakkai Zasshi; 2014 Jun; 111(6):1141-8. PubMed ID: 24898494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus-related fibrosing cholestatic hepatitis in a renal transplant recipient.
    Hooda AK; Puri P; Narula AS; Raychaudhury N; Varghese SJ; Basu A
    Indian J Gastroenterol; 2006; 25(6):308-9. PubMed ID: 17264433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases.
    Evans AT; Loeb KR; Shulman HM; Hassan S; Qiu WC; Hockenbery DM; Ioannou GN; Chauncey TR; Gretch DR; McDonald GB
    Am J Surg Pathol; 2015 Feb; 39(2):212-20. PubMed ID: 25517948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy.
    Toth CM; Pascual M; Chung RT; Graeme-Cook F; Dienstag JL; Bhan AK; Cosimi AB
    Transplantation; 1998 Nov; 66(9):1254-8. PubMed ID: 9825826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritis.
    Saleh F; Ko HH; Davis JE; Apiratpracha W; Powell JJ; Erb SR; Yoshida EM
    Ann Hepatol; 2007; 6(3):186-9. PubMed ID: 17786148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosing cholestatic hepatitis after methotrexate and prednisone therapy for rheumatoid arthritis.
    Topaloğlu S; Çalık A; Kalaycı O; Çeşmecioğlu E; Çobanoğlu Ü; Uzun Y
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():95-7. PubMed ID: 24635802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.